Impact of Eplerenone on Asymptomatic Left Ventricular Diastolic Dysfunction in Diabetic Patients
Phase of Trial: Phase II
Latest Information Update: 07 Dec 2015
At a glance
- Drugs Eplerenone (Primary)
- Indications Left ventricular dysfunction
- Focus Therapeutic Use
- Sponsors Solvotrin Innovations
- 05 Dec 2015 Planned number of patients changed from 30 to 60, according to European Clinical Trials Database record.
- 05 Dec 2015 Status changed from recruiting to completed, European Clinical Trials Database record.
- 27 Aug 2012 New trial record